(Ivanhoe Newswire) – A new kind of Botox could be the answer for forehead
wrinkles.
Used abroad for more than 15 years to treat neurological disorders and wrinkles,
Reloxin – a new Clostridium botulinum toxin type A – has been shown to be well
tolerated and improve the appearance of severe forehead lines in recent America
studies.
Small doses of Reloxin were injected into 1,200 patients at five injection sites
in the forehead. Up to five consecutive treatments were administered over the
next 13-months, with a minimum of 85 days between injections.
Most patients (93 to 95 percent) reported a response to treatment within one
week of treatment and maintained the clinical effect over the duration of the
study with multiple treatments. Adverse effects were experienced by 808
patients, including injection site reactions and nervous system disorders, like
headache and eye drooping.
Notably, Medicis Pharmaceutical Corporation, who manufacturers Reloxin, provided
funding for this study, and the co-author of the study owns stock in and
consults for Medicis.
SOURCE: Archives of Facial Plastic Surgery, 2009;11:77-83
